Asset Dedication’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$24.1K Buy
279
+254
+1,016% +$21.1K ﹤0.01% 620
2026
Q2
$1.68K Buy
+25
New +$1.67K ﹤0.01% 1059
2026
Q1
– Sell
-208
Closed -$13.8K – 1135
2025
Q4
$13.8K Hold
208
– – ﹤0.01% 729
2025
Q3
$14K Hold
208
– – ﹤0.01% 741
2025
Q2
$18.2K Hold
208
– – ﹤0.01% 716
2025
Q1
$14.2K Hold
208
– – ﹤0.01% 709
2024
Q4
$16.2K Buy
+208
New +$15.4K ﹤0.01% 693
2023
Q3
– Sell
-2
Closed – – 1006
2023
Q2
$0 Hold
2
– – ﹤0.01% 978
2023
Q1
$0 Hold
2
– – ﹤0.01% 982
2022
Q4
$0 Buy
+2
New +$220 ﹤0.01% 1028
2022
Q2
– Sell
-164
Closed -$21K – 610
2022
Q1
$21K Hold
164
– – ﹤0.01% 544
2021
Q4
$22K Hold
164
– – ﹤0.01% 527
2021
Q3
$22K Buy
+164
New +$20.7K ﹤0.01% 538
2021
Q1
– Sell
-16
Closed -$1K – 696
2020
Q4
$1K Hold
16
– – ﹤0.01% 737
2020
Q3
$2K Buy
+16
New +$1.67K ﹤0.01% 672
2020
Q1
– Sell
-16
Closed -$1K – 685
2019
Q4
$1K Buy
+16
New +$759 ﹤0.01% 710
2018
Q4
– Sell
-120
Closed -$4K – 603
2018
Q3
$4K Sell
120
-288
-71% -$8.93K ﹤0.01% 534
2018
Q2
$10K Buy
+408
New +$8.65K ﹤0.01% 442
2018
Q1
– Sell
-568
Closed -$8K – 536
2017
Q4
$8K Hold
568
– – ﹤0.01% 370
2017
Q3
$7K Hold
568
– – ﹤0.01% 313
2017
Q2
$10K Hold
568
– – 0.01% 305
2017
Q1
$12K Hold
568
– – 0.01% 297
2016
Q4
$8K Hold
568
– – ﹤0.01% 310
2016
Q3
$12K Sell
568
-568
-50% -$12.6K 0.01% 289
2016
Q2
$23K Hold
1,136
– – 0.02% 226
2016
Q1
$19K Hold
1,136
– – 0.01% 238
2015
Q4
$23K Buy
+1,136
New +$23.6K 0.02% 305

Other funds holding DXCM

Asset Dedication's DXCM Position: Q3 2026 in Review

Asset Dedication increased its DexCom (DXCM) stake by 1,016% in Q3 2026, buying an estimated $21.1K and bringing the position to 279 shares worth $24.1K. The position accounts for ﹤0.01% of the portfolio, ranked #620.

Asset Dedication first reported a position in DXCM in Q4 2015 and has held it in 27 quarters since. 863 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Asset Dedication held 279 shares of DexCom worth $24.1K as of Q3 2026.
  • Asset Dedication bought 254 DexCom shares in Q3 2026, an estimated $21.1K.
  • DexCom made up ﹤0.01% of Asset Dedication's portfolio in Q3 2026, its #620 holding.
  • Asset Dedication first reported a position in DexCom in Q4 2015 and has held it in 27 quarters since.
  • 863 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.